Victoza Clinical Trials
Browse 26 Victoza Medical Studies Across 31 Cities
4 Phase 3 Trial · 38 Victoza Clinics
Receive Treatmentfor Childhood Obesity
Liraglutide Pen Injectorfor Irritable Bowel Syndrome
Liraglutidefor Metabolic Syndrome
Liraglutide Pen Injectorfor Opioid Use Disorder
Liraglutidefor Type 2 Diabetes
L-groupfor Coronary Artery Disease
Liraglutidefor Type 1 Diabetes
Liraglutidefor Type 2 Diabetes
What Are Victoza Clinical Trials?
Victoza is an injectable, prescription medication used to treat type 2 diabetes in adults, and children over the age of 10. It is also used to reduce the risk of heart attack, stroke, and related deaths in adults with type 2 diabetes and known heart conditions.
Victoza clinical trials are important for several reasons. First, they help to ensure that the medication is safe for use in humans. Second, they help to determine whether the medication is effective in treating diabetes. Finally, the clinical trials help to identify any side effects that may occur with the use of Victoza.
Why Is Victoza Being Studied in Clinical Trials?
Victoza is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics some of the behavior of the GLP-1 hormone. This is a hormone that is released after eating and helps to regulate blood sugar levels.
Victoza might be more effective than other diabetes medications because it acts on two pathways involved in regulating blood sugar levels. First, it increases insulin release from the pancreas. Second, it slows gastric emptying.
How Does Victoza Work?
GLP-1 is a naturally occurring hormone that is released when a person eats. GLP-1 slows the release of food from your stomach, thereby controlling blood sugar levels. If food leaves your stomach too quickly, your blood sugar levels can spike. When this happens, your pancreas needs to make extra insulin to regulate blood sugar levels. Victoza works by slowing gastric emptying and increasing insulin levels produced by the pancreas.
What Are Some of The Breakthrough Clinical Trials Involving Victoza?
Some of the recent clinical trials involving Victoza are the following:
2019: A phase 3 clinical trial testing the safety and effectiveness of Victoza as a treatment for type 2 diabetes in children and adolescents. The trial is ongoing and is expected to be completed in 2020.
2012: This clinical trial tested the safety and effectiveness of Victoza as an adjunct to insulin therapy in adults with type 1 diabetes. The study found that Victoza was safe and effective in improving blood sugar control in adults with type 1 diabetes.
Who Are The Key Opinion Leaders On Victoza Clinical Trial Research?
Dr. Satish Garg, MD is a key opinion leader on Victoza clinical trial research. Dr. Garg is a Professor of Medicine at the University of Colorado and the Director of the Diabetes Clinical Research Program at the Barbara Davis Center for Diabetes. Dr. Garg has been involved in Victoza clinical trial research since the medication was first developed. He has conducted several clinical trials testing the safety and effectiveness of Victoza in treating type 2 diabetes.
Dr. Osama Hamdy, MD, PhD, FACE is another key opinion leader on Victoza clinical trial research. Dr. Hamdy is the Medical Director of the Obesity Clinical Program at Brigham and Women’s Hospital and an Associate Professor of Medicine at Harvard Medical School. Dr. Hamdy has conducted several clinical trials testing the safety and effectiveness of Victoza in treating type 2 diabetes.